[Sulfasalazine relieves cholestatic liver injury by activating peroxisome proliferator-activated receptor-α].
Year: 2025
Type: other
Abstract: SASP can improve cholestatic liver injury, and its mechanism is related to the activation of peroxisome proliferator-activated receptor α and the inhibition of Th17 cell differentiation.
Source: PubMed
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
Award: G6664025779
OpenAlex ID: W4411436625
